EVONIK INDUSTRIES AG

Their core work

Evonik is one of Germany's leading specialty chemicals companies, contributing industrial-scale chemical expertise and advanced materials know-how to EU research consortia. Their H2020 involvement spans enzyme-based biocatalysis platforms, biosurfactant production, membrane reactor technology, advanced materials, and energy-efficient building components. They bring real-world manufacturing capability and process scale-up experience, serving as the industrial validation partner that bridges laboratory research and commercial production.

What they specialise in

How they've shifted over time

All of Evonik's H2020 projects launched in 2015-2016, with no new entries in later years, suggesting their EU research engagement was concentrated in a single wave. The early-period keywords are entirely dominated by enzyme engineering terminology — cascade reactions, thermostabilization, microreactor scale-up — pointing to a strong push into industrial biocatalysis. The absence of recent-period keywords and later project starts indicates either a shift toward other funding instruments or a strategic decision to internalize R&D after the initial collaborative phase.

Evonik's H2020 engagement appears to have been a focused 2015-2016 campaign; future collaborators should verify their current EU funding appetite, as they may now pursue Horizon Europe or bilateral industrial partnerships instead.

How they like to work

Evonik never coordinated an H2020 project — they consistently joined as a participant or third party, providing industrial expertise without taking on project management. With 85 unique consortium partners across 15 countries, they engaged broadly rather than deeply with any single partner network. This is typical of a large industrial company that contributes specific capabilities (scale-up, materials, process know-how) to research-led consortia without driving the research agenda.

Evonik collaborated with 85 distinct partners across 15 countries, indicating a wide but shallow European network typical of a large multinational joining diverse research consortia rather than building a tight cluster of repeat collaborators.

What sets them apart

Evonik brings genuine industrial-scale specialty chemicals manufacturing to research consortia — they are not a research organization pretending to have industry relevance, but a €15B+ revenue company with actual production facilities. Their dual strength in both enzyme-based biocatalysis and advanced materials makes them unusually versatile for projects that need to bridge biotechnology and chemical engineering. For consortium builders, Evonik provides the credible industrial end-user validation that EU evaluators look for.

Highlights from their portfolio

• CARBAZYMES
  Core enzyme engineering platform project covering the full chain from enzyme discovery to technical-scale cascade reactions for APIs and bulk chemicals.
• CARBOSURF
  Evonik was involved both as participant and third party, indicating deep commitment to fermentative biosurfactant production across multiple work packages.
• EENSULATE
  Longest-running project (2016-2021) in the portfolio, addressing energy-efficient building components — a departure from their core chemistry focus.